# AHSP

## Overview
The AHSP gene encodes the alpha hemoglobin stabilizing protein, a molecular chaperone predominantly expressed in erythroid cells. This protein plays a critical role in the stabilization of free alpha-hemoglobin (αHb) by preventing its denaturation and precipitation, which can lead to oxidative damage and cytotoxicity. AHSP achieves this by binding specifically to αHb, facilitating its proper folding and assembly with beta hemoglobin (βHb) to form functional hemoglobin A (HbA). The interaction between AHSP and αHb is characterized by a strong and specific binding affinity, which is crucial for maintaining erythrocyte stability and function. Mutations or altered expression of the AHSP gene can exacerbate conditions such as β-thalassemia by increasing the cytotoxic effects of excess free α-globin, highlighting its clinical significance as a genetic modifier in hemoglobinopathies (Gallagher2005GATA1; Mollan2010The; Kong2004Loss).

## Structure
The alpha hemoglobin stabilizing protein (AHSP) is a small protein composed of 102 amino acids, expressed exclusively in erythroid cells. Its primary structure includes a specific sequence of amino acids that form a three-helix bundle, which is crucial for its function as a molecular chaperone (Mollan2010The; Brillet2010αHemoglobin).

The secondary structure of AHSP is predominantly alpha-helical, with the wild-type (WT) form exhibiting approximately 74% alpha-helix content at 25°C. The AHSP V56G mutant, however, shows a reduced alpha-helix content, indicating partial unfolding at ambient temperatures (Brillet2010αHemoglobin).

In terms of tertiary structure, AHSP adopts a compact three-helix bundle conformation. This structure is stabilized by interactions between its helices and the G and H helices of alpha-hemoglobin (α-Hb), which are critical for maintaining the stability and proper folding of α-Hb (Brillet2010αHemoglobin; DominguesHamdi2014Role).

AHSP's quaternary structure involves its interaction with α-Hb, forming a complex that prevents the aggregation of free alpha-globin chains. This interaction is essential for hemoglobin assembly and function (Mollan2010The; DominguesHamdi2014Role). The AHSP-α-Hb complex is characterized by a specific hydrodynamic diameter, indicating a defined tertiary structure when bound to α-Hb (DominguesHamdi2014Role).

## Function
The alpha hemoglobin stabilizing protein (AHSP) plays a crucial role in erythropoiesis by acting as a molecular chaperone for free alpha-hemoglobin (αHb) in erythroid cells. AHSP binds specifically to αHb, stabilizing its structure and preventing its denaturation and precipitation, which can lead to the production of reactive oxygen species (ROS) and oxidative damage (Mollan2010The; Kong2004Loss). This stabilization is essential for maintaining αHb in a soluble state until it can associate with beta hemoglobin (βHb) to form hemoglobin A (HbA) (DominguesHamdi2014Role).

AHSP's interaction with αHb involves binding to the G and H helices of αHb, overlapping with the α1-β1 interface of HbA, which prevents the accumulation of free α or β subunits that are cytotoxic (WEISS2005Role). This binding induces conformational changes in αHb, converting it to a less reactive bis-histidyl hemichrome form, thereby limiting the reactivity of heme iron and reducing oxidative stress (WEISS2005Role).

In the absence of AHSP, as observed in AHSP-deficient mice, there is an increase in α-globin precipitation, ROS production, and oxidative damage, leading to erythrocyte instability and ineffective erythropoiesis (Kong2004Loss). AHSP is primarily active in the cytoplasm of erythroid precursor cells, where it ensures the proper assembly and function of hemoglobin, thus playing a vital role in red blood cell integrity and function (Mollan2010The).

## Clinical Significance
Mutations and alterations in the expression of the AHSP gene have significant clinical implications, particularly in the context of hemoglobinopathies such as β-thalassemia. AHSP plays a critical role in stabilizing free α-globin chains, and its deficiency can exacerbate the symptoms of β-thalassemia by increasing the cytotoxic effects of excess free α-globin, leading to oxidative damage and ineffective erythropoiesis (Gallagher2005GATA1; Kong2004Loss). In β-thalassemia, the absence or reduced expression of AHSP results in increased precipitation of α-globin, contributing to the severity of the disease (Kong2004Loss).

Studies have identified specific mutations in the AHSP gene that are associated with more severe thalassemic phenotypes. For instance, mutations in exon 3 of the AHSP gene have been linked to transfusion-dependent thalassemia in patients with HbE β-thalassemia (Ray2019Association). Additionally, variations in AHSP expression levels can influence the clinical severity of thalassemia, with reduced expression correlating with more severe disease manifestations (Che2020Alphahemoglobinstabilizing; Lai2006α‐Haemoglobin). These findings suggest that AHSP acts as a genetic modifier in thalassemia, affecting disease severity and patient management.

## Interactions
AHSP (alpha hemoglobin stabilizing protein) specifically interacts with free alpha-globin subunits, forming a stable 1:1 complex that prevents the precipitation of alpha-globin, which is crucial in conditions like beta-thalassemia (Kihm2002An; Gell2002Biophysical). This interaction does not require the heme group and is characterized by an association constant of 1 x 10^7 M^-1, indicating a strong and specific binding (Santiveri2004NMR; Gell2002Biophysical). AHSP binds to alpha-globin at specific regions, including the C terminus of helix 1, loop 1, and the N terminus of helix 2, with key residues such as Phe-47 and Tyr-51 playing a significant role in molecular recognition (Santiveri2004NMR).

AHSP does not bind to beta-globin or tetrameric hemoglobin, highlighting its specificity for alpha-globin (Gell2002Biophysical). The interaction between AHSP and alpha-globin is transient, allowing AHSP to facilitate the proper folding and assembly of alpha-globin with beta-globin to form hemoglobin A (Yu2007An). This chaperone activity is crucial for maintaining erythroid cell health and preventing the cytotoxic effects of free alpha-globin (Yu2007An).


## References


[1. (Che2020Alphahemoglobinstabilizing) Nur Suraya Che Yaacob, Md Asiful Islam, Heba Alsaleh, Ibrahim Khidir Ibrahim, and Rosline Hassan. Alpha-hemoglobin-stabilizing protein (ahsp): a modulatory factor in β-thalassemia. International Journal of Hematology, 111(3):352–359, January 2020. URL: http://dx.doi.org/10.1007/s12185-019-02806-8, doi:10.1007/s12185-019-02806-8. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12185-019-02806-8)

[2. (WEISS2005Role) MITCHELL J. WEISS, SUIPING ZHOU, LIANG FENG, DAVID A. GELL, JOEL P. MACKAY, YIGONG SHI, and ANDREW J. GOW. Role of alpha hemoglobin‐stabilizing protein in normal erythropoiesis and β‐thalassemia. Annals of the New York Academy of Sciences, 1054(1):103–117, November 2005. URL: http://dx.doi.org/10.1196/annals.1345.013, doi:10.1196/annals.1345.013. This article has 37 citations and is from a peer-reviewed journal.](https://doi.org/10.1196/annals.1345.013)

[3. (DominguesHamdi2014Role) Elisa Domingues-Hamdi, Corinne Vasseur, Jean-Baptiste Fournier, Michael C. Marden, Henri Wajcman, and Véronique Baudin-Creuza. Role of α-globin h helix in the building of tetrameric human hemoglobin: interaction with α-hemoglobin stabilizing protein (ahsp) and heme molecule. PLoS ONE, 9(11):e111395, November 2014. URL: http://dx.doi.org/10.1371/journal.pone.0111395, doi:10.1371/journal.pone.0111395. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0111395)

[4. (Ray2019Association) Rudra Ray, Siddhesh Arun Kalantri, Sunistha Bhattacharjee, Ankita Biswas, Aiman Shahab, Sujana Biswas, and Maitreyee Bhattacharyya. Association of alpha hemoglobin–stabilizing protein (ahsp) gene mutation and disease severity among hbe—beta thalassemia patients. Annals of Hematology, 98(8):1827–1834, June 2019. URL: http://dx.doi.org/10.1007/s00277-019-03722-x, doi:10.1007/s00277-019-03722-x. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00277-019-03722-x)

[5. (Brillet2010αHemoglobin) Thomas Brillet, Véronique Baudin-Creuza, Corinne Vasseur, Elisa Domingues-Hamdi, Laurent Kiger, Henri Wajcman, Serge Pissard, and Michael C. Marden. Α-hemoglobin stabilizing protein (ahsp), a kinetic scheme of the action of a human mutant, ahspv56g. Journal of Biological Chemistry, 285(23):17986–17992, June 2010. URL: http://dx.doi.org/10.1074/jbc.m109.098491, doi:10.1074/jbc.m109.098491. This article has 22 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m109.098491)

[6. (Lai2006α‐Haemoglobin) Mei I. Lai, Jie Jiang, Nicholas Silver, Steve Best, Stephan Menzel, Aleksandar Mijovic, Stefano Colella, Jiannis Ragoussis, Chad Garner, Mitchell J. Weiss, and Swee L. Thein. Α‐haemoglobin stabilising protein is a quantitative trait gene that modifies the phenotype of β‐thalassaemia. British Journal of Haematology, 133(6):675–682, May 2006. URL: http://dx.doi.org/10.1111/j.1365-2141.2006.06075.x, doi:10.1111/j.1365-2141.2006.06075.x. This article has 55 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/j.1365-2141.2006.06075.x)

[7. (Kihm2002An) Anthony J. Kihm, Yi Kong, Wei Hong, J. Eric Russell, Susan Rouda, Kazuhiko Adachi, M. Celeste Simon, Gerd A. Blobel, and Mitchell J. Weiss. An abundant erythroid protein that stabilizes free α-haemoglobin. Nature, 417(6890):758–763, June 2002. URL: http://dx.doi.org/10.1038/nature00803, doi:10.1038/nature00803. This article has 229 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nature00803)

[8. (Yu2007An) Xiang Yu, Yi Kong, Louis C. Dore, Osheiza Abdulmalik, Anne M. Katein, Suiping Zhou, John K. Choi, David Gell, Joel P. Mackay, Andrew J. Gow, and Mitchell J. Weiss. An erythroid chaperone that facilitates folding of α-globin subunits for hemoglobin synthesis. Journal of Clinical Investigation, 117(7):1856–1865, July 2007. URL: http://dx.doi.org/10.1172/jci31664, doi:10.1172/jci31664. This article has 86 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci31664)

[9. (Santiveri2004NMR) Clara M. Santiveri, José Manuel Pérez-Cañadillas, Murali K. Vadivelu, Mark D. Allen, Trevor J. Rutherford, Nicholas A. Watkins, and Mark Bycroft. Nmr structure of the α-hemoglobin stabilizing protein. Journal of Biological Chemistry, 279(33):34963–34970, August 2004. URL: http://dx.doi.org/10.1074/jbc.m405016200, doi:10.1074/jbc.m405016200. This article has 48 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m405016200)

[10. (Mollan2010The) Todd L. Mollan, Xiang Yu, Mitchell J. Weiss, and John S. Olson. The role of alpha-hemoglobin stabilizing protein in redox chemistry, denaturation, and hemoglobin assembly. Antioxidants &amp; Redox Signaling, 12(2):219–231, January 2010. URL: http://dx.doi.org/10.1089/ars.2009.2780, doi:10.1089/ars.2009.2780. This article has 37 citations.](https://doi.org/10.1089/ars.2009.2780)

[11. (Gell2002Biophysical) David Gell, Yi Kong, Sally A. Eaton, Mitchell J. Weiss, and Joel P. Mackay. Biophysical characterization of the α-globin binding protein α-hemoglobin stabilizing protein. Journal of Biological Chemistry, 277(43):40602–40609, October 2002. URL: http://dx.doi.org/10.1074/jbc.m206084200, doi:10.1074/jbc.m206084200. This article has 91 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m206084200)

[12. (Gallagher2005GATA1) Patrick G. Gallagher, Robert I. Liem, Ellice Wong, Mitchell J. Weiss, and David M. Bodine. Gata-1 and oct-1 are required for expression of the human α-hemoglobin-stabilizing protein gene. Journal of Biological Chemistry, 280(47):39016–39023, November 2005. URL: http://dx.doi.org/10.1074/jbc.m506062200, doi:10.1074/jbc.m506062200. This article has 32 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m506062200)

[13. (Kong2004Loss) Yi Kong, Suiping Zhou, Anthony J. Kihm, Anne M. Katein, Xiang Yu, David A. Gell, Joel P. Mackay, Kazuhiko Adachi, Linda Foster-Brown, Calvert S. Louden, Andrew J. Gow, and Mitchell J. Weiss. Loss of α-hemoglobin–stabilizing protein impairs erythropoiesis and exacerbates β-thalassemia. Journal of Clinical Investigation, 114(10):1457–1466, November 2004. URL: http://dx.doi.org/10.1172/jci200421982, doi:10.1172/jci200421982. This article has 10 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci200421982)